GlassScriptPhysician profile
Omar Behery
NPI 1215316484
$88,541.33
in general payments reported to CMS, 2019-2025
12 companies · $26K in 2025
The $26K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $952 · 2021: $1,347 · 2022: $918 · 2023: $30K · 2024: $29K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Travel and Lodging: $15K · Food and Beverage: $5,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,762.50 |
| Travel and Lodging | $15,445.60 |
| Food and Beverage | $5,116.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $73,482.60 | 2020-2025 | Mpact, Amistem, Quadra |
| Onkos Surgical, INC. | $5,004.77 | 2024-2025 | Eleos Limb Salvage System |
| Stryker Corporation | $3,920.23 | 2020-2025 | Insignia, Trident, Pangea |
| Signature Orthopaedics USA Corp | $3,000.00 | 2024 | |
| Encore Medical, LP | $1,366.32 | 2022-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $923.55 | 2020-2025 | Zmr, Avenir |
| Depuy Synthes Sales INC. | $405.04 | 2021-2024 | Emphasys, Attune, Velys |
| Omnilife Science, INC | $159.84 | 2023-2024 | Various Products, Omnibotics 3.0 |
| Medical Device Business Services, INC. | $140.18 | 2021 | |
| Heron Therapeutics, INC. | $79.57 | 2021 | |
| Smith+Nephew, INC. | $41.16 | 2020 | |
| Heraeus Medical, LLC. | $18.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Behery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.